Atlas Trials

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Clinical trial NCT04708782 · COMPLETED

Trial details

NCT number
NCT04708782
Sponsor
United Therapeutics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Pulmonary FibrosisInterstitial Lung Disease
Start date
2021-06-01
Primary completion
2026-02-02
Enrollment
598

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.